Characterization of CD326-positive human hepatic stem cells

Area of Science:

• Hepatology and stem cell biology.
• Cellular and molecular biology.

Background:

• CD326 is a marker for hepatic stem cells, but its expression in bile duct epithelium complicates purification.
• Previous studies proposed co-expressed markers, but lacked systematic comparison.

Purpose of the Study:

• To systematically compare cell surface markers for hepatic stem cell identification.
• To determine the co-expression patterns of CD326 with other potential stem cell markers in human liver.

Main Methods:

• Immunohistochemistry analyzed CD326 expression across human liver developmental stages.
• Flow cytometry quantified co-expression of CD326 with CD56, CD117, CD44, CD90, CD49f, LGR5, and SSEA4 in fetal liver cells.
• Gene expression analysis of progenitor and hepatic lineage markers was performed on isolated cell fractions.

Main Results:

• 12.5% of cells expressed CD326, with 63.5% co-expressing CD44. SSEA4 and LGR5 showed low co-expression (2.1% and 0.7%, respectively).
• Cells co-expressing CD326 and SSEA4 exhibited high expression of proliferation (MKi67) and hepatic markers (DLK1, AFP, ALB).
• The CD326+SSEA4+ fraction was negative for the biliary marker KRT19, unlike other CD326+ fractions.

Conclusions:

• CD326+ cells are heterogeneous; combining CD326 with SSEA4 can differentiate hepatic stem cells from bile duct epithelium.
• This marker combination aids in the precise classification of human hepatic progenitor cell populations.